Definium Therapeutics, Inc.
DFTX- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001813814
In the last 90 days, Definium Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 362 institutions reported holding it in 13F filings for Q2 2026, worth $5.35B in total; Duquesne Family Office is the only superinvestor holding it.
Q3 2025 vs. Q2 2025
How the institutions holding Definium Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 183 | 2 | 196 | +15 |
| Shares | 41.8M | 11.1K | 39.7M | −2.05M (−4.9%) |
| Value | $271.0M | $72.3K | $468.6M | +$197.6M (+72.9%) |
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (39)
Institutions that held Definium Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (24)
Institutions that held Definium Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Woodline Partners LP | 502,198 | $3.26M |
| Oppenheimer & Co Inc | 98,336 | $638.2K |
| Balyasny Asset Management LLC | 38,937 | $252.7K |
| XTX Topco Ltd | 32,402 | $210.3K |
| Polar Asset Management Partners Inc. | 29,300 | $190.2K |
| Mitchell McLeod Pugh & Williams Inc | 20,000 | $129.8K |
| Squarepoint Ops LLC | 19,684 | $127.7K |
| ExodusPoint Capital Management, LP | 17,877 | $116.0K |
| Bailard, Inc. | 14,600 | $94.8K |
| Diametric Capital, LP | 12,433 | $80.7K |
| PEAK6 LLC | 10,915 | $70.8K |
| Sharpepoint LLC | 10,165 | $66.0K |
| Capital Advisors Inc | 50,000 | $37.5K |
| Clear Street Markets LLC | 3,096 | $20.1K |
| Larson Financial Group LLC | 2,932 | $19.0K |
| Skopos Labs, Inc. | 519 | $3.37K |
| SRS Capital Advisors, Inc. | 501 | $3.25K |
| IFP Advisors, Inc | 0 | $2.82K |
| Caitong International Asset Management Co., Ltd | 341 | $2.21K |
| CarsonAllaria Wealth Management, Ltd. | 325 | $2.11K |
| Pandora Wealth, Inc. | 131 | $850 |
| First Pacific Financial | 102 | $662 |
| TruNorth Capital Management, LLC | 33 | $214 |
| Total Investment Management Inc | 20 | $130 |
Not filed for Q3 2025 yet (2)
Institutions that held Definium Therapeutics, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Avantax Advisory Services, Inc. | 11,138 | $72.3K |
| Belmont Capital, LLC | 6 | $39 |